Dr. Slikker received his Ph.D. in pharmacology and toxicology from the University of California at Davis. He performed his postdoctoral training in the Perinatal Research Program at FDA’s National Center for Toxicological Research and at the Institute of Toxicology and Embryopharmacology, Freie Universität, Berlin.

Dr. Slikker holds adjunct professorships in the Department of Pediatrics, and the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences. He has held leadership positions in several scientific societies including the Teratology Society, the MidSouth Computational Biology and Bioinformatics Society, the American Society for Pharmacology and Experimental Therapeutics, and the Society of Toxicology.

Dr. Slikker has authored or co-authored over 300 publications in the areas of transplacental pharmacokinetics, developmental neurotoxicology, neuroprotection, systems biology, and risk assessment.

Dr. Slikker is a co-founder of the International Conference on Neuroprotective Agents. He has served on national and international advisory panels including those for the Health and Environmental Sciences Institute/International Life Sciences Institute, the U.S. Environmental Protection Agency, the National Institutes of Health, the National Academy of Sciences, and the World Health Organization. Dr. Slikker is also an invited member of the Academy of Toxicological Sciences and Associate Editor for NeuroToxicology and Toxicological Sciences.